OPEN END-TURBO-OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 12:35:02 27/06/2024 BST | ||
| 1.36 EUR | 0.00% |
|
| Current month | +5.43% | ||
| 1 month | +5.43% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 27/06/24 | 1.36 | 0.00% |
| 26/06/24 | 1.36 | -3.55% |
| 25/06/24 | 1.41 | +2.17% |
| 24/06/24 | 1.38 | +3.76% |
| 21/06/24 | 1.33 | +0.76% |
Real-time BOERSE MUENCHEN
Last update June 27, 2024 at 12:35 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | TT019Z |
| ISIN | DE000TT019Z4 |
| Date issued | 27/02/2020 |
| Strike | 169.1 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.54 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.5 € |
|---|---|
| Lowest since issue | 0.27 € |
| Spread | 0.02 € |
| Spread % | 1.47% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.8
USD
Average target price
316.4
USD
Spread / Average Target
+1.16%
- Stock Market
- Certificates
- Certificat
